Intrauterine infection/inflammation and perinatal brain damage: Role of glial cells and Toll-like receptor signaling

Journal of Neuroimmunology

Volumn 229, Issue 1-2, 2010, Pages 16-25

  Yuan, Tian Ming ^a   Sun, Yi ^a   Zhan, Can Yang ^a   Yu, Hui Min ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Glial cell; Inflammation; Intrauterine infection; Toll like receptors; White matter damage

Indexed keywords

CD14 ANTIGEN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; INTERFERON REGULATORY FACTOR 7; INTERLEUKIN 1 RECEPTOR ASSOCIATED KINASE; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELOID DIFFERENTIATION FACTOR 88; RANTES; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ALZHEIMER DISEASE; ASTROCYTE; BRAIN DAMAGE; BRAIN INJURY; ESCHERICHIA COLI; GLIA CELL; GRAM NEGATIVE BACTERIUM; HUMAN; IMMUNOMODULATION; INFLAMMATION; INNATE IMMUNITY; INTRAUTERINE INFECTION; LIPID RAFT; MICROGLIA; MULTIPLE SCLEROSIS; NEUROIMMUNOLOGY; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; STREPTOCOCCUS PNEUMONIAE;

ANIMALS; BRAIN DISEASES; FEMALE; HUMANS; MODELS, BIOLOGICAL; NEUROGLIA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 78650308146     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.08.008     Document Type: Review

References (114)

1. Abrahams V.M., Aldo P.B., Murphy S.P., Visintin I., Koga K., Wilson G., Romero R., Sharma S., Mor G. TLR6 modulates first trimester trophoblast responses to peptidoglycan. J. Immunol. 2008, 180:6035-6043.
2. Abrahams V.M., Visintin I., Aldo P.B., Guller S., Romero R., Mor G. A role for TLRs in the regulation of immune cell migration by first trimester trophoblast cells. J. Immunol. 2005, 175:8096-8104.
3. Adams Waldorf K.M., Persing D., Novy M.J., Sadowsky D.W., Gravett M.G. Pretreatment with toll-like receptor 4 antagonist inhibits lipopolysaccharide-induced preterm uterine contractility, cytokines, and prostaglandins in rhesus monkeys. Reprod. Sci. 2008, 15:121-127.
4. Akira S., Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol. 2004, 4:499-511.
5. Akira S., Takeda K., Kaisho T. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2001, 2:675-680.
6. Allan S.M., Rothwell N.J. Cytokines and acute neurodegeneration. Nat. Rev. Neurosci. 2001, 2:734-744.
7. Aravalli R.N., Peterson P.K., Lokensgard J.R. Toll-like receptors in defense and damage of the central nervous system. J. Neuroimmune Pharmacol. 2007, 2:297-312.
8. Aschner M. Immune and inflammatory responses in the CNS: modulation by astrocytes. Toxicol. Lett. 1998, 102-103:283-287.
9. Barna B.P., Estes M.L., Jacobs B.S., Hudson S., Ransohoff R.M. Human astrocytes proliferate in response to tumor necrosis factor alpha. J. Neuroimmunol. 1990, 30:239-243.
10. Bell M.J., Hallenbeck J.M., Gallo V. Determining the fetal inflammatory response in an experimental model of intrauterine inflammation in rats. Pediatr. Res. 2004, 56:541-546.
11. Belt A.R., Baldassare J.J., Molnar M., Romero R., Hertelendy F. The nuclear transcription factor NF-kB mediates interleukin-1b-induced expression of cyclooxygenase-2 in human myometrial cells. Am. J. Obstet. Gynecol. 1999, 181:359-366.
12. Briscoe T., Duncan J., Cock M., Choo J., Rice G., Harding R., Scheerlinck J.P., Rees S. Activation of NF-kappaB transcription factor in the preterm ovine brain and placenta after acute LPS exposure. J. Neurosci. Res. 2006, 83:567-574.
13. Bsibsi M., Persoon-Deen C., Verwer R.W., Meeuwsen S., Ravid R., Van Noort J.M. Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 2006, 53:688-695.
14. Bsibsi M., Ravid R., Gveric D., van Noort J.M. Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 2002, 61:1013-1021.
15. Buchanan M.M., Hutchinson M., Watkins L.R., Yin H. Toll-like receptor 4 in CNS pathologies. J. Neurochem. 2010, 114:13-27.
16. Campbell A. Inflammation, neurodegenerative diseases, and environmental exposures. Ann. N.Y. Acad. Sci. 2004, 1035:117-132.
17. Carpentier P.A., Begolka W.S., Olson J.K., Elhofy A., Karpus W.J., Miller S.D. Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 2005, 49:360-374.
18. Carpentier P.A., Duncan D.S., Miller S.D. Glial toll-like receptor signaling in central nervous system infection and autoimmunity. Brain Behav. Immun. 2008, 22:140-147.
19. Chen J.C., Ho F.M., Pei-Dawn Lee Chao, Chen C.P., Jeng K.C., Hsu H.B., Lee S.T., Wen Tung W., Lin W.W. Inhibition of iNOS gene expression by quercetin is mediated by the inhibition of IkappaB kinase, nuclear factor-kappa B and STAT1, and depends on hemeoxygenase-1 induction in mouse BV-2 microglia. Eur. J. Pharmacol. 2005, 521:9-20.
20. Dammann O., Leviton A. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn. Pediatr. Res. 1997, 42:1-8.
21. Debillon T., Gras-Leguen C., Verielle V., Winer N., Caillon J., Roze J.C., Gressens P. Intrauterine infection induces programmed cell death in rabbit periventricular white matter. Pediatr. Res. 2000, 47:736-742.
22. Deguchi K., Mizuguchi M., Takashima S. Immunohistochemical expression of tumor necrosis factor alpha in neonatal leukomalacia. Pediatr. Neurol. 1996, 14:13-16.
23. DiDonato J.A., Hayakawa M., Rothwarf D.M., Zandi E., Karin M.A. Cytokine-responsive I-kappa B kinase that activates the transcription factor NF-kappa B. Nature 1997, 388:548-554.
24. Drexler S.K., Foxwell B.M. The role of Toll-like receptors in chronic inflammation. Int. J. Biochem. Cell Biol. 2010, 42:506-518.
25. Elovitz M.A., Mrinalini C., Sammel M.D. Elucidating the early signal transduction pathways leading to fetal brain injury in preterm birth. Pediatr. Res. 2006, 59:50-55.
26. Espinoza J., Chaiworapongsa T., Romero R., Gomez R., Kim J.C., Yoshimatsu J., Edwin S., Rathnasabapathy C., Yoon B.H. Evidence of participation of soluble CD14 in the host response to microbial invasion of the amniotic cavity and intra-amniotic inflammation in term and preterm gestations. J. Matern.-Fetal Neonatal Med. 2002, 12:304-312.
27. Feldhaus B., Dietzel I.D., Berger R. TNF-α induces cell death in primary cultures of oligodendrocyte progenitors. J. Soc. Gynecol. Investig. 2001, 8:248A.
28. Filipov N.M., Seegal R.F., Lawrence D.A. Manganese potentiates in vitro production of proinflammatory cytokines and nitric oxide by microglia through a nuclear factor kappa B-dependent mechanism. Toxicol. Sci. 2005, 84:139-148.
29. Filipovich Y., Lu S.J., Akira S., Hirsch E. The adaptor protein MyD88 is essential for E coli-induced preterm delivery in mice. Am. J. Obstet. Gynecol. 2009, 200:93.e1-8.
30. Frøen J.F., Munkeby B.H., Stray-Pedersen B., Saugstad O.D. Interleukin-10 reverses acute detrimental effects of endotoxin-induced inflammation on perinatal cerebral hypoxia-ischemia. Brain Res. 2002, 942:87-94.
31. Gee J.R., Keller J.N. Astrocytes: regulation of brain homeostasis via apolipoprotein E. Int. J. Biochem. Cell Biol. 2005, 37:1145-1150.
32. Girvin A.M., Gordon K.B., Welsh C.J., Clipstone N.A., Miller S.D. Differential abilities of central nervous system resident endothelial cells and astrocytes to serve as inducible antigen-presenting cells. Blood 2002, 99:3692-3701.
33. Golan H.M., Lev V., Hallak M., Sorokin Y., Huleihel M. Specific neurodevelopmental damage in mice offspring following maternal inflammation during pregnancy. Neuropharmacology 2005, 48:903-917.
34. Guha M., Mackman N. LPS induction of gene expression in human monocytes. Cell. Signal. 2001, 13:85-94.
35. Hagberg H., Mallard C. Effect of inflammation on central nervous system development and vulnerability. Curr. Opin. Neurol. 2005, 18:117-123.
36. Harju K., Ojaniemi M., Rounioja S., Glumoff V., Paananen R., Vuolteenaho R., Hallman M. Expression of toll-like receptor 4 and endotoxin responsiveness in mice during perinatal period. Pediatr. Res. 2005, 57:644-648.
37. Heales S.J., Bolanos J.P., Stewart V.C., Brookes P.S., Land J.M., Clark J.B. Nitric oxide, mitochondria and neurological disease. Biochim. Biophys. Acta 1999, 1410:215-228.
38. Herrmann I., Kellert M., Schmidt H., Mildner A., Hanisch U.K., Bruck W., Prinz M., Nau R. Streptococcus pneumoniae infection aggravates experimental autoimmune encephalomyelitis via Toll-like receptor 2. Infect. Immun. 2006, 74:4841-4848.
39. Hoffmann J.A., Kafatos F.C., Janeway C.A., Ezekowitz R.A. Phylogenetic perspectives in innate immunity. Science 1999, 284:1313-1318.
40. Hoshino K., Takeuchi O., Kawai T., Sanjo H., Ogawa T., Takeda Y., Takeda K., Akira S. Cutting edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide: evidence for TLR4 as the Lps gene product. J. Immunol. 1999, 162:3749-3752.
41. Hunot S., Hirsch E.C. Neuroinflammatory processes in Parkinson's disease. Ann. Neurol. 2003, 53(Suppl 3):S49-S58. discussion S58-60.
42. Inder T.E., Wells S.J., Mogridge N.B., Spencer C., Volpe J.J. Defining the nature of the cerebral abnormalities in the premature infant: a qualitative magnetic resonance imaging study. J. Pediatr. 2003, 143:171-179.
43. Jack C.S., Arbour N., Manusow J., Montgrain V., Blain M., McCrea E., Shapiro A., Antel J.P. TLR signaling tailors innate immune responses in human microglia and astrocytes. J. Immunol. 2005, 175:4320-4330.
44. Jackson S.K., Abate W., Parton J., Jones S., Harwood J.L. Lysophospholipid metabolism facilitates Toll-like receptor 4 membrane translocation to regulate the inflammatory response. J. Leukoc. Biol. 2008, 84:86-92.
45. Jensen A., Garnier Y., Middelanis J., Berger R. Perinatal brain damage-from pathophysiology to prevention. Eur. J. Obstet. Gynecol. Reprod. Biol. 2003, 110:S70-S79.
46. Jin J.J., Kim H.D., Maxwell J.A., Li L., Fukuchi K. Toll-like receptor 4-dependent upregulation of cytokines in a transgenic mouse model of Alzheimer's disease. J. Neuroinflammation 2008, 5:23.
47. Jung H.S., Yoon B.H., Jun J.K., Kim M., Kim Y.A., Kim C.J. Differential activation of mitogen activated protein kinases and nuclear factor-κB in lipopolysaccharide-treated term and preterm amnion cells. Virchows Arch. 2005, 447:45-52.
48. Karikó K., Weissman D., Welsh F.A. Inhibition of toll-like receptor and cytokine signaling-a unifying theme in ischemic tolerance. J. Cereb. Blood Flow Metab. 2004, 24:1288-1304.
49. Kawai T., Akira S. TLR signaling. Cell Death Differ. 2006, 13:816-825.
50. Kitamura Y., Nomura Y. Stress proteins and glial functions: possible therapeutic targets for neurodegenerative disorders. Pharmacol. Ther. 2003, 97:35-53.
51. Kopp E., Medzhitov R. Recognition of microbial infection by Toll-like receptors. Curr. Opin. Immunol. 2003, 15:396-401.
52. Lappas M., Permezel M., Georgiou H.M., Rice G.E. Nuclear factor-kB regulation of pro-inflammatory cytokines in human gestational tissues in vitro. Biol. Reprod. 2002, 67:668-673.
53. Lappas M., Permezel M., Georgiou H.M., Rice G.E. Regulation of phospholipase isozymes by nuclear factor-kB in human gestational tissues in vitro. J. Clin. Endocrinol. Metab. 2004, 89:2365-2372.
54. Lehnardt S., Lachance C., Patrizi S., Lefebvre S., Follett P.L., Jensen F.E., Rosenberg P.A., Volpe J.J., Vartanian T. The toll-like receptor TLR4 is necessary for lipopolysaccharide-induced oligodendrocyte injury in the CNS. J. Neurosci. 2002, 22:2478-2486.
55. Leviton A., Dammann O., Durum S.K. The adaptive immune response in neonatal cerebral white matter damage. Ann. Neurol. 2005, 58:821-828.
56. Leviton A., Paneth N., Reuss M.L., Susser M., Allred E.N., Dammann O., Kuban K., Van Marter L.J., Pagano M., Hegyi T., Hiatt M., Sanocka U., Shahrivar F., Abiri M., Disalvo D., Doubilet P., Kairam R., Kazam E., Kirpekar M., Rosenfeld D., Schonfeld S., Share J., Collins M., Genest D., Shen-Schwarz S. Maternal infection, fetal inflammatory response, and brain damage in very low birth weight infants. Pediatr. Res. 1999, 46:566-575.
57. Li J., Baud O., Vartanian T., Volpe J.J., Rosenberg P.A. Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:9936-9941.
58. Lyng K., Munkeby B.H., Saugstad O.D., Stray-Pedersen B., Frøen J.F. Effect of interleukin-10 on newborn piglet brain following hypoxia-ischemia and endotoxin-induced inflammation. Biol. Neonate 2005, 87:207-216.
59. Ma Y., Li J., Chiu I., Wang Y., Sloane J.A., Lu J., Kosaras B., Sidman R.L., Volpe J.J., Vartanian T. Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J. Cell Biol. 2006, 175:209-215.
60. Mallard C., Wang X., Hagberg H. The role of Toll-like receptors in perinatal brain injury. Clin. Perinatol. 2009, 36:763-772.
61. Mallard C., Welin A.K., Peebles D., Hagberg H., Kjellmer I. White matter injury following systemic endotoxemia or asphyxia in the fetal sheep. Neurochem. Res. 2003, 28:215-223.
62. Mancuso G., Midiri A., Beninati C., Piraino G., Valenti A., Nicocia G., Teti D., Cook J., Teti G. Mitogen-activated protein kinases and NF-kappa B are involved in TNF-alpha responses to group B streptococci. J. Immunol. 2002, 169:1401-1409.
63. Marta M., Meier U.C., Lobell A. Regulation of autoimmune encephalomyelitis by toll-like receptors. Autoimmun. Rev. 2009, 8:506-509.
64. Martins de Lima T., Gorjão R., Hatanaka E., Cury-Boaventura M.F., Portioli Silva E.P., Procopio J., Curi R. Mechanisms by which fatty acids regulate leucocyte function. Clin. Sci. (Lond) 2007, 113:65-77.
65. McGeer P.L., McGeer E.G. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res. Brain Res. Rev. 1995, 21:195-218.
66. McKimmie C.S., Fazakerley J.K. In response to pathogens, glial cells dynamically and differentially regulate Toll-like receptor gene expression. J. Neuroimmunol. 2005, 169:116-125.
67. Medzhitov R. Toll-like receptors and innate immunity. Nat. Rev. Immunol. 2001, 1:135-145.
68. Mercurio F., Zhu H., Murray B.W., Shevchenko A., Bennett B.L., Li J., Young D.B., Barbosa M., Mann M., Manning A., Rao A. IKK-1 and IKK-2: cytokineactivated IkappaB kinases essential for NF-kappaB activation. Science 1997, 278:860-866.
69. Merrill J.E., Benveniste E.N. Cytokines in inflammatory brain lesions: helpful and harmful. Trends Neurosci. 1996, 19:331-338.
70. Minoretti P., Gazzaruso C., Vito C.D., Emanuele E., Bianchi M., Coen E., Reino M., Geroldi D. Effect of the functional toll like receptor 4 Asp299Gly polymorphism on susceptibility to lateonset Alzheimer's disease. Neurosci. Lett. 2006, 391:147-149.
71. Muñoz-Fernández M.A., Fresno M. The role of tumour necrosis factor, interleukin 6, interferon-gamma and inducible nitric oxide synthase in the development and pathology of the nervous system. Prog. Neurobiol. 1998, 56:307-340.
72. Nakano H., Shindo M., Sakon S., Nishinaka S., Mihara M., Yagita H., Okumura K. Differential regulation of IkappaB kinase alpha and beta by two upstream kinases, NF-kappaB-inducing kinase and mitogen-activated protein kinase/ERK kinase kinase-1. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:3537-3542.
73. Okoshi Y., Itoh M., Takashima S. Characteristic neuropathology and plasticity in periventricular leukomalacia. Pediatr. Neurol. 2001, 25:221-226.
74. Okun E., Griffioen K.J., Gen Son T., Lee J.H., Roberts N.J., Mughal M.R., Hutchison E., Cheng A., Arumugam T.V., Lathia J.D., van Praag H., Mattson M.P. TLR2 activation inhibits embryonic neural progenitor cell proliferation. J. Neurochem. 2010, 114:462-474.
75. Okun E., Griffioen K.J., Lathia J.D., Tang S.C., Mattson M.P., Arumugam T.V. Toll-like receptors in neurodegeneration. Brain Res. Rev. 2009, 59:278-292.
76. Olson J.K., Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 2004, 173:3916-3924.
77. Ospelt C., Gay S. TLRs and chronic inflammation. Int. J. Biochem. Cell Biol. 2010, 42:495-505.
78. Owens T. The enigma of multiple sclerosis: inflammation and neurodegeneration cause heterogeneous dysfunction and damage. Curr. Opin. Neurol. 2003, 16:259-265.
79. Paintlia M.K., Paintlia A.S., Barbosa E., Singh I., Singh A.K. N-acetylcysteine prevents endotoxin-induced degeneration of oligodendrocyte progenitors and hypomyelination in developing rat brain. J. Neurosci. Res. 2004, 78:347-361.
80. Paintlia M.K., Paintlia A.S., Singh A.K., Singh I. Attenuation of lipopolysaccharide-induced inflammatory response and phospholipids metabolism at the fetal-maternal interface by N-acetyl cysteine. Pediatr. Res. 2008, 64:334-339.
81. Pang Y., Cai Z., Rhodes P.G. Disturbance of oligodendrocyte development, hypomyelination and white matter injury in the neonatal rat brain after intracerebral injection of lipopolysaccharide. Brain Res. Dev. Brain Res. 2003, 140:205-214.
82. Pirianov G., Waddington S.N., Lindström T.M., Terzidou V., Mehmet H., Bennett P.R. The cyclopentenone 15-deoxy-delta 12, 14-prostaglandin J(2) delays lipopolysaccharide-induced preterm delivery and reduces mortality in the newborn mouse. Endocrinology 2009, 150:699-706.
83. Possel H., Noack H., Putzke J., Wolf G., Sies H. Selective upregulation of inducible nitric oxide synthase (iNOS) by lipopolysaccharide (LPS) and cytokines in microglia: in vitro and in vivo studies. Glia 2000, 32:51-59.
84. Prince L.S., Dieperink H.I., Okoh V.O., Fierro-Perez G.A., Lallone R.L. Toll-like receptor signaling inhibits structural development of the distal fetal mouse lung. Dev. Dyn. 2005, 233:553-561.
85. Prince L.S., Okoh V.O., Moninger T.O., Matalon S. Lipopolysaccharide increases alveolar type II cell number in fetal mouse lungs through Toll-like receptor 4 and NF-kappaB. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 287:L999-L1006.
86. Prinz M., Garbe F., Schmidt H., Mildner A., Gutcher I., Wolter K., Piesche M., Schroers R., Weiss E., Kirschning C.J., Rochford C.D., Brück W., Becher B. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J. Clin. Invest. 2006, 116:456-464.
87. Rezaie P., Dean A. Periventricular leukomalacia, inflammation and white matter lesions within the developing nervous system. Neuropathology 2002, 22:106-132.
88. Rivest S. Molecular insights on the cerebral innate immune system. Brain Behav. Immun. 2003, 17:13-19.
89. Rounioja S., Rasanen J., Ojaniemi M., Glumoff V., Autio-Harmainen H., Hallman M. Mechanism of acute fetal cardiovascular depression after maternal inflammatory challenge in mouse. Am. J. Pathol. 2005, 166:1585-1592.
90. Rousset C.I., Chalon S., Cantagrel S., Bodard S., Andres C., Gressens P., Saliba E. Maternal exposure to LPS induces hypomyelination in the internal capsule and programmed cell death in the deep gray matter in newborn rats. Pediatr. Res. 2006, 59:428-433.
91. Salminen A., Paananen R., Vuolteenaho R., Metsola J., Ojaniemi M., Autio-Harmainen H., Hallman M. Maternal endotoxin-induced preterm birth in mice: fetal responses in toll-like receptors, collectins, and cytokines. Pediatr. Res. 2008, 63:280-286.
92. Schmitz T., Chew L.J. Cytokines and myelination in the central nervous system. Sci. World J. 2008, 8:1119-1147.
93. Sharangpania A., Takanohashia A., Bell M.J. Caspase activation in fetal rat brain following experimental intrauterine inflammation. Brain Res. 2008, 1200:138-145.
94. Shen S., Yu S., Binek J. Distinct signaling pathways for induction of type II NOS by IFN-r and LPS in BV-2 microglial cells. Neuroscience 2005, 22:3352-3358.
95. Shen Y., Yu H.M., Yuan T.M., Gu W.Z., Wu Y.D. Intrauterine infection induced oligodendrocyte injury and inducible nitric oxide synthase expression in developing rat brain. J. Perinat. Med. 2007, 35:203-209.
96. Simons K., Toomre D. Lipid rafts and signal transduction. Nat. Rev. Mol. Cell Biol. 2000, 1:31-39.
97. Streit W.J., Conde J.R., Fendrick S.E., Flanary B.E., Mariani C.L. Role of microglia in the central nervous system's immune response. Neurol. Res. 2005, 27:685-691.
98. Takeda K., Akira S. Toll-like receptors in innate immunity. Int. Immunol. 2005, 17:1-14.
99. Touil T., Fitzgerald D., Zhang G.X., Rostami A., Gran B. Cutting edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta. J. Immunol. 2006, 177:7505-7509.
100. Triantafilou M., Miyake K., Golenbock D.T., Triantafilou K. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell Sci. 2002, 115:2603-2611.
101. Underhill D.M., Ozinsky A. Toll-like receptors: key mediators of microbe detection. Curr. Opin. Immunol. 2002, 14:103-110.
102. Vela J.M., Molina-Holgado E., Arevalo-Martin A., Almazan G., Guaza C. Interleukin-1 regulates proliferation and differentiation of oligodendrocyte progenitor cells. Mol. Cell. Neurosci. 2002, 20:489-502.
103. Vlope J.J. Neonatal encephalitis and white matter injury: more than just inflammation?. Ann. Neurol. 2008, 64:232-236.
104. Volpe J.J. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr. Res. 2001, 50:553-562.
105. Volpe J.J. Neurology of the Newborn 1995, 294-299. Saunders, Philadelphia, PA. third edition.
106. Wang X., Hagberg H., Nie C., Zhu C., Ikeda T., Mallard C. Dual role of intrauterine immune challenge on neonatal and adult brain vulnerability to hypoxia-ischemia. J. Neuropathol. Exp. Neurol. 2007, 66:552-561.
107. Wang X., Stridh L., Li W., Dean J., Elmgren A., Gan L., Eriksson K., Hagberg H., Mallard C. Lipopolysaccharide sensitizes neonatal hypoxic-ischemic brain injury in a MyD88-dependent manner. J. Immunol. 2009, 183:7471-7477.
108. Walter S., Letiembre M., Liu Y., Heine H., Penke B., Hao W., Bode B., Manietta N., Walter J., Schulz-Schuffer W., Fassbender K. Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease. Cell. Physiol. Biochem. 2007, 20:947-956.
109. Weiss J.M., Berman J.W. Astrocyte expression of monocyte chemoattractant protein-1 is differentially regulated by transforming growth factor beta. J. Neuroimmunol. 1998, 91:190-197.
110. Yabe T., Sanagi T., Schwartz J.P., Yamada H. Pigment epithelium-derived factor induces pro-inflammatory genes in neonatal astrocytes through activation of NF-kappa B and CREB. Glia 2005, 50:223-234.
111. Yamada K., Komori Y., Tanaka T., Senzaki K., Nikai T., Sugihara H., Kameyama T., Nabeshima T. Brain dysfunction associated with an induction of nitric oxide synthase following an intracerebral injection of lipopolysaccharide in rats. Neuroscience 1999, 88:281-294.
112. Yoon B.H., Jun J., Romero R., Park K., Gomez R., Choi J., Kim I. Amniotic fluid inflammatory cytokines (interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha), neonatal brain white matter lesions, and cerebral palsy. Am. J. Obstet. Gynecol. 1997, 177:19-26.
113. Yu H.M., Yuan T.M., Gu W.Z., Li J.P. Expression of glial fibrillary acidic protein in developing rat brain after intrauterine infection. Neuropathology 2004, 24:136-143.
114. Yuan T.M., Yu H.M., Gu W.Z., Li J.P. White matter damage and chemokine induction in developing rat brain after intrauterine infection. J. Perinat. Med. 2005, 33:415-422.